论文部分内容阅读
从法治政府的角度来看,对于电子监管系统最终如何运营以及监管,还是应该采取政府行政监管、协同共治、行业企业自治相结合的思路来决策,并通过公开的听证会、专家论证会听取民意,开门决策、透明决策2016年1月25日,湖南养天和大药房企业集团有限公司(以下简称“养天和”)对国家食品药品监督管理总局(下称食药监总局)提起了行政诉讼,请求确认食药监总局强制推行阿里健康旗下公司运营的电子监管码的行政行为违法,并判令被告立即停止违法行为;同时诉请法院对被告制定的《药品经营质量
From the point of view of the rule of law government, decision-making should be taken based on the idea of combining government administrative supervision, co-governance and industry autonomy with the regulation of how the electronic regulatory system ultimately operates and be supervised. Public hearings and expert testimony hearings Public Opinion, Open Door Policy and Transparent Policy Decision On January 25, 2016, Hunan Yangtian Pharmaceutical Group Co., Ltd. (hereinafter referred to as “Yangtianhe”) issued a letter to the State Food and Drug Administration (CFDA) Filed an administrative lawsuit and requested confirmation of the administrative act of the SFDA to impose the electronic regulatory code that enforces the operation of the company under Ali Health and violated the law and ordered the defendant to immediately stop the illegal act. At the same time, the court was requested to prosecute the defendant’s "Quality of Drug Administration